Rajnish Mago, MD

Dr Mago is the director of the psychopharmacology curriculum for the Penn Psychiatry Residency Program at the University of Pennsylvania in Philadelphia, PA. He also teaches psychiatry residents at the SUNY Upstate Medical University in Syracuse, NY. He is the chair of the education committees for both the Pennsylvania Psychiatric Society and the Philadelphia Psychiatric Society.

Articles by Rajnish Mago, MD

Beyond Deprescribing: A Formula for Excellent Clinical Care

ByJoseph F. Goldberg, MD,Anita H. Clayton, MD,Leslie L. Citrome, MD, MPH,David W. Goodman, MD,Rajnish Mago, MD,Roger S. McIntyre, MD, FRCPC,Holly A. Swartz, MD,Mauricio Tohen, MD,John J. Miller, MD,Psychiatric Times Editors

July 13th 2026

A panel of expert psychiatrists define deprescribing as ongoing medication review, guiding safer, personalized psychopharmacology amid polypharmacy, misdiagnosis, and fragmented care.

Podcast: Deprescribing Insights From an ASCP Panel of Psychiatric Experts

ByJoseph F. Goldberg, MD,Roger S. McIntyre, MD, FRCPC,Rajnish Mago, MD,Anita H. Clayton, MD,Holly A. Swartz, MD,David W. Goodman, MD ,Leslie L. Citrome, MD, MPH,Mauricio Tohen, MD

July 3rd 2026

ASCP panel offers deprescribing guidance to curb psychiatric overprescribing, simplify polypharmacy, and improve outcomes with tapering and

Brain Trust: The First Panel of Psychiatric Experts Weighs in on Deprescribing at ASCP 2026

ByJoseph F. Goldberg, MD,Roger S. McIntyre, MD, FRCPC,Rajnish Mago, MD,Anita H. Clayton, MD,Holly A. Swartz, MD,David W. Goodman, MD ,Leslie L. Citrome, MD, MPH,Mauricio Tohen, MD

May 28th 2026

Expert psychiatrists share new ASCP deprescribing guidance, tackling overprescribing, primary-care challenges, and practical tapering strategies to improve safer, patient-centered mental health care.

Sleep Hygiene: Tips on Getting a Restful Night's Sleep

ByRajnish Mago, MD

March 9th 2016

Concerned about daylight savings time? This patient handout offers tips for getting a good night's sleep.

Lamotrigine for Major Depressive Disorder Is Inappropriate

ByRajnish Mago, MD

April 11th 2013

Lamotrigine is an important option in bipolar disorders. However, many clinicians also use it in patients with a (unipolar) depressive disorder who have not responded adequately to conventional antidepressants.

Antidepressants and Persistent Pulmonary Hypertension of the Newborn

ByRajnish Mago, MD

August 2nd 2012

It appears that the risk is greater with antidepressant use during late pregnancy but may be elevated with use during early pregnancy as well.

Bupropion After Nonresponse or Partial Response to an SSRI or SNRI?

ByRajnish Mago, MD

March 1st 2012

While SSRIs and SNRIs are valuable in the treatment of major depression, partial response or nonresponse occurs in many patients. Research has found that bupropion was the most frequently chosen agent for addition to an SSRI after inadequate response.

Efficacy of Drugs in Bipolar Depression: What the Data Show

ByRajnish Mago, MD

May 12th 2010

This is the second installment of a new series in which clinically relevant research is briefly discussed and, perhaps more important, a few tips on how to read and interpret research studies are presented. Your feedback, suggestions, and questions are eagerly solicited at rajnish.mago@jefferson.edu.

Sleep Hygiene

ByRajnish Mago, MD

December 11th 2009

Simple but powerful suggestions to get a better night's sleep.

Practical Implications of a Study on Treating Chronic Insomnia

ByRajnish Mago, MD

December 1st 2009

More than a thousand articles on mental disorders are published in medical journals each month! Also, clinicians have limited training, time, and inclination to keep up with reading research articles critically on a regular basis. Thus, a disturbing disconnect (for which there are no easy solutions) exists between clinical research and usual clinical practice.

Coffee, Cigarettes and Meds: What Are the Metabolic Effects?

ByNarsimha R. Pinninti, MD,Rajnish Mago, MD,Jose De Leon, MD

May 1st 2005

Heavy smoking and caffeine intake are highly prevalent in patients with psychiatric disorders, both of which significantly impact the metabolism of a number of psychotropic medications. Hence, these factors should be routinely considered in making prescribing decisions.